Thomas Rodermann has left the board of the Luxembourg asset manager Quintet, to which Merck Finck belongs as a brand.
The former UBS Germany boss Rodermann started on January 1, 2020 as a reorganizer at the traditional Munich bank Merck Finck, which was still operating with its own banking license at the time.
At that time, he succeeded Matthias Schellenberg, who now heads the Apotheker- und Ärztebank, as Chairman of the Board.
When Merck Finck was merged with seven other subsidiaries in the course of 2020, Rodermann became European head of Quintet (formerly KBL).
A spokesman for Quintet told the FAZ without giving any further explanations.
As head of Europe, Rodermann was initially responsible for merging the subsidiaries.
Under the leadership of Jürg Zeltner, Quintet also bought the Swiss Bank Bellevue and expanded it in 2020 as a third pillar in parallel with the business in Luxembourg and London.
However, Zeltner died unexpectedly in March 2020 and Quintet gave up its Swiss activities again in 2022.
So there was less for Rodermann to do.
Finally, there is a separate management for the national companies.
In March 2021, for example, Quintet brought in Reinhard Krafft from Rothschild & Co as head of Germany and responsible for the Merck Finck brand.
Rodermann's career reached a high point when he was CEO of Deutsche Bank Privat- und Firmenkundenbank from 2011 to 2015 and then moved to the major Swiss bank UBS as head of Germany.
In 2019 he lost a power struggle against Christine ("Christl") Novakovic.